13-45151783-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004128.3(GTF2F2):āc.256C>Gā(p.Gln86Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000479 in 1,585,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00026 ( 0 hom., cov: 31)
Exomes š: 0.000025 ( 0 hom. )
Consequence
GTF2F2
NM_004128.3 missense
NM_004128.3 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 6.26
Genes affected
GTF2F2 (HGNC:4653): (general transcription factor IIF subunit 2) Predicted to enable RNA polymerase II general transcription initiation factor activity. Involved in transcription by RNA polymerase II. Located in microtubule cytoskeleton and nucleoplasm. Part of transcription preinitiation complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24816355).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2F2 | NM_004128.3 | c.256C>G | p.Gln86Glu | missense_variant | 4/8 | ENST00000340473.8 | NP_004119.1 | |
GTF2F2 | XM_011535052.4 | c.256C>G | p.Gln86Glu | missense_variant | 4/9 | XP_011533354.1 | ||
GTF2F2 | XM_011535053.4 | c.256C>G | p.Gln86Glu | missense_variant | 4/6 | XP_011533355.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2F2 | ENST00000340473.8 | c.256C>G | p.Gln86Glu | missense_variant | 4/8 | 1 | NM_004128.3 | ENSP00000340823 | P1 | |
GTF2F2 | ENST00000706694.1 | c.85C>G | p.Gln29Glu | missense_variant, NMD_transcript_variant | 1/6 | ENSP00000516507 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 151918Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
40
AN:
151918
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000581 AC: 14AN: 241072Hom.: 0 AF XY: 0.0000384 AC XY: 5AN XY: 130344
GnomAD3 exomes
AF:
AC:
14
AN:
241072
Hom.:
AF XY:
AC XY:
5
AN XY:
130344
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000251 AC: 36AN: 1433548Hom.: 0 Cov.: 25 AF XY: 0.0000224 AC XY: 16AN XY: 714284
GnomAD4 exome
AF:
AC:
36
AN:
1433548
Hom.:
Cov.:
25
AF XY:
AC XY:
16
AN XY:
714284
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000263 AC: 40AN: 151918Hom.: 0 Cov.: 31 AF XY: 0.000216 AC XY: 16AN XY: 74176
GnomAD4 genome
AF:
AC:
40
AN:
151918
Hom.:
Cov.:
31
AF XY:
AC XY:
16
AN XY:
74176
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
10
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.256C>G (p.Q86E) alteration is located in exon 4 (coding exon 4) of the GTF2F2 gene. This alteration results from a C to G substitution at nucleotide position 256, causing the glutamine (Q) at amino acid position 86 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at